Compare Enveric Biosciences Inc (ENVB) vs SkyWest Inc (SKYW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs SkyWest Inc — how do they compare? Enveric Biosciences Inc trades at $1.37 (market cap $5.32M), while SkyWest Inc trades at $100.18 (market cap $3.95B). The key difference: SkyWest Inc is far larger — about 742.5× Enveric Biosciences Inc's market cap, and SkyWest Inc is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | SKYW | |
|---|---|---|
Market Cap | $5.32M | $3.95B |
Sector | Health | Technology |
52-Week High | $17.40 | $123.72 |
52-Week Low | $1.28 | $78.40 |
Enterprise Value | $408.82K | $5.79B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.38, up 4.55% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported a net loss of $8.77M for 2025, though it beat EPS estimates in all four quarters. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003, including IND-enabling studies and positive preclinical results.
Outlook hinges on clinical progress, with 75% analyst buy ratings supporting potential upside, but high financial losses and negative ROE/ROA pose significant risks. Investors face volatility from regulatory developments and funding needs, making it speculative despite positive sentiment from recent operational updates.
SkyWest (SKYW) trades at $100.55, up 3.46% on the day, with a bullish technical signal and strong analyst support. The stock shows attractive valuation multiples with a P/E of 9.54 and P/S of 0.99, while maintaining solid profitability with a 10.42% net income margin and 16.5% ROE. Recent earnings have mostly beaten expectations, and the company announced new executive leadership with Wade Steel as President and COO of SkyWest Airlines.
The outlook appears positive given the consensus price target of $109.33 (8.7% upside) and unanimous 'Buy' or 'Hold' analyst ratings. Key risks include rising fuel costs impacting airline industry margins and potential earnings volatility, though the company's strong cash flow generation and conservative valuation provide downside protection.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About SkyWest Inc
SkyWest, Inc. is a major North American regional airline company, operating primarily through its subsidiary, SkyWest Airlines. The company provides regional airline service to various large airlines under contract, including United Airlines (as United Express), Delta Air Lines (as Delta Connection), American Airlines (as American Eagle), and Alaska Airlines (as Alaska SkyWest). SKYW's primary business is providing essential flight services, connecting smaller cities to major airline hubs across the United States.
Read more on SKYW →
